The documentation extends the investigation for cartelization to 14 prepaid companies that were left out of the precautionary measure ordered by the CNDC.
The presentation was made by the same members of the CC who presented the complaint in January, which the CNDC used to determine that there are multiple indications of a collusive agreement between the main prepaid medicine companies in the country.
The Civic Coalition demands that the National Commission for the Defense of Competition (CNDC) include all prepaid companies in the precautionary measure presented on Wednesday. “The Government cannot ignore the abuse of the middle class by a group of companies. The Government has the duty to care for all users of prepaid medicine,” they maintained.
The documentation extends the investigation into cartelization to 14 prepaid companies that were left out of the precautionary measure ordered by the CNDC.
The presentation was made by the same members of the CC who presented the complaint in January, which the CNDC used to determine that there are multiple indications of a collusive agreement between the main prepaid medicine companies in the country. The leaders are Hernán Reyes; Maximiliano Ferraro; Rubén Manzi and Facundo del Gaiso.
The final objective of the request to expand the evidence before the National Commission for the Defense of Competition is for the Superintendency of National Health Services to provide the documentation it has in its possession about the prepaid medicine companies included in the cartelization case.
“The CC requires the Superintendency to contribute to the investigation and present all the communications that the prepaid medicine companies have made to their users; that presents the complete registry of prepaid medicine companies throughout the country, according to their participation in the market; and to recover the health index that measures the impact of the variation in prices of services related to health provision,” the party maintains.
In dialogue with Ambit, The CC admits that “it views with great concern the lack of willingness of the Superintendency of Health Services to collaborate in the file” since it did not incorporate the other companies before the precautionary measure was issued.
“The Government that first deregulated without being aware of the impact of that measure, enabled cartelization and tremendous increases in prepaid medicine. They have the responsibility and the tools to investigate all the companies that were part of the cartel,” concluded the legislators who signed the complaint.
Source: Ambito
